Addition of Amide Proton Transfer Imaging to FDG-PET/CT Improves Diagnostic Accuracy in Glioma Grading: A Preliminary Study Using the Continuous Net Reclassification Analysis

Overview

Journal AJNR Am J Neuroradiol

Specialty Neurology

Date 2018 Jan 6

PMID 29301781

Citations 7

Authors

A Sakata

T Okada

Y Yamamoto

Y Fushimi

T Dodo

Y Arakawa

Y Mineharu

B Schmitt

S Miyamoto

K Togashi

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Amide proton transfer imaging has been successfully applied to brain tumors, however, the relationships between amide proton transfer and other quantitative imaging values have yet to be investigated. The aim was to examine the additive value of amide proton transfer imaging alongside [F] FDG-PET and DWI for preoperative grading of gliomas.

Materials And Methods: Forty-nine patients with newly diagnosed gliomas were included in this retrospective study. All patients had undergone MR imaging, including DWI and amide proton transfer imaging on 3T scanners, and [F] FDG-PET. Logistic regression analyses were conducted to examine the relationship between each imaging parameter and the presence of high-grade (grade III and/or IV) glioma. These parameters included the tumor-to-normal ratio of FDG uptake, minimum ADC, mean amide proton transfer value, and their combinations. In each model, the overall discriminative power for the detection of high-grade glioma was assessed with receiver operating characteristic curve analysis. Additive information from minimum ADC and mean amide proton transfer was also evaluated by continuous net reclassification improvement. < .05 was considered significant.

Results: Tumor-to-normal ratio, minimum ADC, and mean amide proton transfer demonstrated comparable diagnostic accuracy in differentiating high-grade from low-grade gliomas. When mean amide proton transfer was combined with the tumor-to-normal ratio, the continuous net reclassification improvement was 0.64 (95% CI, 0.036-1.24; = .04) for diagnosing high-grade glioma and 0.95 (95% CI, 0.39-1.52; = .001) for diagnosing glioblastoma. When minimum ADC was combined with the tumor-to-normal ratio, the continuous net reclassification improvement was 0.43 (95% CI, -0.17-1.04; = .16) for diagnosing high-grade glioma, and 1.36 (95% CI, 0.79-1.92; < .001) for diagnosing glioblastoma.

Conclusions: Addition of amide proton transfer imaging to FDG-PET/CT may improve the ability to differentiate high-grade from low-grade gliomas.

Citing Articles

Three-dimensional amide proton transfer (APT) imaging appliable to navigation surgery can present comparable metabolic activity of glioblastoma to C-Methionine PET.

Inoue A, Watanabe H, Kusakabe K, Nishikawa M, Ohtsuka S, Shiraishi Y Acta Neurochir (Wien). 2025; 167(1):49.

PMID: 39969596 PMC: 11839683. DOI: 10.1007/s00701-025-06465-z.

Role of amide proton transfer imaging in maximizing tumor resection in malignant glioma: a possibility to take the place of C-methionine positron emission tomography.

Inoue A, Watanabe H, Kusakabe K, Nishikawa M, Shiraishi Y, Taniwaki M Neurosurg Rev. 2023; 46(1):294.

PMID: 37925381 DOI: 10.1007/s10143-023-02202-1.

Neuroimaging at 7 Tesla: a pictorial narrative review.

Okada T, Fujimoto K, Fushimi Y, Akasaka T, Thuy D, Shima A Quant Imaging Med Surg. 2022; 12(6):3406-3435.

PMID: 35655840 PMC: 9131333. DOI: 10.21037/qims-21-969.

Amide proton transfer imaging for differentiation of tuberculomas from high-grade gliomas: Preliminary experience.

Kulanthaivelu K, Jabeen S, Saini J, Raju S, Nalini A, Sadashiva N Neuroradiol J. 2021; 34(5):440-448.

PMID: 33823712 PMC: 8559025. DOI: 10.1177/19714009211002766.

Endogenous Chemical Exchange Saturation Transfer MRI for the Diagnosis and Therapy Response Assessment of Brain Tumors: A Systematic Review.

Okuchi S, Hammam A, Golay X, Kim M, Thust S Radiol Imaging Cancer. 2021; 2(1):e190036.

PMID: 33778693 PMC: 7983695. DOI: 10.1148/rycan.2020190036.

References

Ma B, Blakeley J, Hong X, Zhang H, Jiang S, Blair L . Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas. J Magn Reson Imaging. 2016; 44(2):456-62. PMC: 4946988. DOI: 10.1002/jmri.25159. View

Yoon J, Kim J, Kang W, Sohn C, Choi S, Yun T . Grading of cerebral glioma with multiparametric MR imaging and 18F-FDG-PET: concordance and accuracy. Eur Radiol. 2013; 24(2):380-9. DOI: 10.1007/s00330-013-3019-3. View

Pencina M, DAgostino Sr R, DAgostino Jr R, Vasan R . Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2007; 27(2):157-72. DOI: 10.1002/sim.2929. View

Park J, Kim H, Park K, Kim S, Kim J, Smith S . Pre- and Posttreatment Glioma: Comparison of Amide Proton Transfer Imaging with MR Spectroscopy for Biomarkers of Tumor Proliferation. Radiology. 2015; 278(2):514-23. DOI: 10.1148/radiol.2015142979. View

Vinogradov E, Sherry A, Lenkinski R . CEST: from basic principles to applications, challenges and opportunities. J Magn Reson. 2013; 229:155-72. PMC: 3602140. DOI: 10.1016/j.jmr.2012.11.024. View

Nguyen T, Cron G, Perdrizet K, Bezzina K, Torres C, Chakraborty S . Comparison of the Diagnostic Accuracy of DSC- and Dynamic Contrast-Enhanced MRI in the Preoperative Grading of Astrocytomas. AJNR Am J Neuroradiol. 2015; 36(11):2017-22. PMC: 7964869. DOI: 10.3174/ajnr.A4398. View

Sagiyama K, Mashimo T, Togao O, Vemireddy V, Hatanpaa K, Maher E . In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma. Proc Natl Acad Sci U S A. 2014; 111(12):4542-7. PMC: 3970489. DOI: 10.1073/pnas.1323855111. View

Collins V, Jones D, Giannini C . Pilocytic astrocytoma: pathology, molecular mechanisms and markers. Acta Neuropathol. 2015; 129(6):775-88. PMC: 4436848. DOI: 10.1007/s00401-015-1410-7. View

Server A, Kulle B, Gadmar O, Josefsen R, Kumar T, Nakstad P . Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Eur J Radiol. 2010; 80(2):462-70. DOI: 10.1016/j.ejrad.2010.07.017. View

10.

Bai Y, Lin Y, Zhang W, Kong L, Wang L, Zuo P . Noninvasive amide proton transfer magnetic resonance imaging in evaluating the grading and cellularity of gliomas. Oncotarget. 2016; 8(4):5834-5842. PMC: 5351593. DOI: 10.18632/oncotarget.13970. View

11.

Manabe O, Hattori N, Yamaguchi S, Hirata K, Kobayashi K, Terasaka S . Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging. Eur J Nucl Med Mol Imaging. 2015; 42(6):896-904. DOI: 10.1007/s00259-015-2996-7. View

12.

Yamashita K, Yoshiura T, Hiwatashi A, Togao O, Yoshimoto K, Suzuki S . Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography. Neuroradiology. 2012; 55(2):135-43. DOI: 10.1007/s00234-012-1089-6. View

13.

Koschmann C, Calinescu A, Nunez F, Mackay A, Fazal-Salom J, Thomas D . ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma. Sci Transl Med. 2016; 8(328):328ra28. PMC: 5381643. DOI: 10.1126/scitranslmed.aac8228. View

14.

Zhou J, Lal B, Wilson D, Laterra J, van Zijl P . Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med. 2003; 50(6):1120-6. DOI: 10.1002/mrm.10651. View

15.

Togao O, Yoshiura T, Keupp J, Hiwatashi A, Yamashita K, Kikuchi K . Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro Oncol. 2013; 16(3):441-8. PMC: 3922507. DOI: 10.1093/neuonc/not158. View

16.

Halligan S, Altman D, Mallett S . Disadvantages of using the area under the receiver operating characteristic curve to assess imaging tests: a discussion and proposal for an alternative approach. Eur Radiol. 2015; 25(4):932-9. PMC: 4356897. DOI: 10.1007/s00330-014-3487-0. View

17.

Choi Y, Ahn S, Lee S, Chang J, Kang S, Kim S . Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume. Eur Radiol. 2017; 27(8):3181-3189. PMC: 5746027. DOI: 10.1007/s00330-017-4732-0. View

18.

Zhou J, Payen J, Wilson D, Traystman R, van Zijl P . Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med. 2003; 9(8):1085-90. DOI: 10.1038/nm907. View

19.

Schmitt B, Zaiss M, Zhou J, Bachert P . Optimization of pulse train presaturation for CEST imaging in clinical scanners. Magn Reson Med. 2011; 65(6):1620-9. DOI: 10.1002/mrm.22750. View

20.

Fudaba H, Shimomura T, Abe T, Matsuta H, Momii Y, Sugita K . Comparison of multiple parameters obtained on 3T pulsed arterial spin-labeling, diffusion tensor imaging, and MRS and the Ki-67 labeling index in evaluating glioma grading. AJNR Am J Neuroradiol. 2014; 35(11):2091-8. PMC: 7965191. DOI: 10.3174/ajnr.A4018. View